공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

아시아태평양의 오소바이오로직스 시장 전망

Asia-Pacific Orthobiologics Market Outlook to 2025 - Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others

리서치사 GlobalData
발행일 2021년 02월 상품 코드 676472
페이지 정보 영문 202 Pages
가격
US $ 5,995 ₩ 6,703,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,990 ₩ 13,407,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 17,985 ₩ 20,110,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


아시아태평양의 오소바이오로직스 시장 전망 Asia-Pacific Orthobiologics Market Outlook to 2025 - Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair and Others
발행일 : 2021년 02월 페이지 정보 : 영문 202 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

아시아태평양 국가(호주, 중국, 인도, 일본, 한국)의 오소바이오로직스(Orthobiologics) 시장에 대해 분석했으며, 지역 전체 시장 동향 추정과 전망(과거 3년간, 향후 8년간), 국가별·제품별 동향, 주요 기업·유통 채널의 시장 점유율, 주요 파이프라인 제품의 현재 임상시험 상황, 최근의 자본 거래·사업 추진 동향, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 목차

제2장 서론

  • 본 보고서의 개요
  • 오소바이오로직스 시장 세분화
  • 분석 대상 정의

제3장 아시아태평양의 오소바이오로직스 시장

  • 시장 매출 : 국가별(금액 기준, 통산 11년간)
  • 시장 매출 : 제품 종류별(금액 기준, 통산 11년간)
  • 시장 규모 : 국가별(수량 기준, 통산 11년간)
  • 시장 규모 : 제품 종류별(수량 기준, 통산 11년간)
  • 시장 매출 점유율 : 기업별

제4장 호주의 오소바이오로직스 시장

  • 시장 매출(금액 기준, 통산 11년간)
  • 시장 규모(수량 기준, 통산 11년간)
  • 평균 가격(통산 11년간)
  • 시장 매출 점유율 : 유통 채널별
  • 시장 매출 점유율 : 기업별

제5장 중국의 오소바이오로직스 시장

제6장 인도의 오소바이오로직스 시장

제7장 일본의 오소바이오로직스 시장

제8장 한국의 오소바이오로직스 시장

제9장 주요 기업 분석 : 아시아태평양의 오소바이오로직스 시장

  • Sanofi
  • Seikagaku Corp
  • DePuy Synthes Inc
  • Stryker Corp
  • Medtronic Plc
  • Chugai Pharmaceutical Co Ltd
  • Zimmer Biomet Holdings Inc
  • Shandong Haiyou Freda Pharmacy Co Ltd
  • Bioventus LLC

제10장 오소바이오로직스 시장의 파이프라인 제품

제11장 최근 동향

  • 기업 홍보
  • 결산 발표
  • 제품 뉴스

제12장 부록

KSM 18.08.28

List of Tables

List of Tables

  • Table 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2015-2025
  • Table 2: Orthobiologics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2015-2020
  • Table 3: Orthobiologics Market, Asia

List of Figures

List of Figures

  • Figure 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2015-2025
  • Figure 2: Orthobiologics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2015-2025
  • Figure 3: Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025
  • Figure 4: Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025
  • Figure 5: Orthobiologics Market, Asia-Pacific, Company Share (%) 2019
  • Figure 6: Orthobiologics Market, Australia, Revenue ($m), USD Constant, 2015-2025
  • Figure 7: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, 2015-2025
  • Figure 8: Bone Growth Stimulators Market, Australia, Revenue ($m), USD Constant, 2015-2025
  • Figure 9: Cartilage Repair Market, Australia, Revenue ($m), USD Constant, 2015-2025
  • Figure 10: Soft Tissue Biologics Market, Australia, Revenue ($m), USD Constant, 2015-2025
  • Figure 11: Viscosupplementation Market, Australia, Revenue ($m), USD Constant, 2015-2025
  • Figure 12: Orthobiologics Market, Australia, Volume (Units), 2015-2025
  • Figure 13: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2015-2025
  • Figure 14: Bone Growth Stimulators Market, Australia, Volume (Units), 2015-2025
  • Figure 15: Cartilage Repair Market, Australia, Volume (Units), 2015-2025
  • Figure 16: Soft Tissue Biologics Market, Australia, Volume (Units), 2015-2025
  • Figure 17: Viscosupplementation Market, Australia, Volume (Units), 2015-2025
  • Figure 18: Orthobiologics Market, Australia, Company Share (%) 2019
  • Figure 19: Orthobiologics Market, China, Revenue ($m), USD Constant, 2015-2025
  • Figure 20: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, 2015-2025
  • Figure 21: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, 2015-2025
  • Figure 22: Cartilage Repair Market, China, Revenue ($m), USD Constant, 2015-2025
  • Figure 23: Soft Tissue Biologics Market, China, Revenue ($m), USD Constant, 2015-2025
  • Figure 24: Viscosupplementation Market, China, Revenue ($m), USD Constant, 2015-2025
  • Figure 25: Orthobiologics Market, China, Volume (Units), 2015-2025
  • Figure 26: Bone Grafts and Substitutes Market, China, Volume (Units), 2015-2025
  • Figure 27: Bone Growth Stimulators Market, China, Volume (Units), 2015-2025
  • Figure 28: Cartilage Repair Market, China, Volume (Units), 2015-2025
  • Figure 29: Soft Tissue Biologics Market, China, Volume (Units), 2015-2025
  • Figure 30: Viscosupplementation Market, China, Volume (Units), 2015-2025
  • Figure 31: Orthobiologics Market, China, Company Share (%) 2019
  • Figure 32: Orthobiologics Market, India, Revenue ($m), USD Constant, 2015-2025
  • Figure 33: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, 2015-2025
  • Figure 34: Bone Growth Stimulators Market, India, Revenue ($m), USD Constant, 2015-2025
  • Figure 35: Cartilage Repair Market, India, Revenue ($m), USD Constant, 2015-2025
  • Figure 36: Soft Tissue Biologics Market, India, Revenue ($m), USD Constant, 2015-2025
  • Figure 37: Viscosupplementation Market, India, Revenue ($m), USD Constant, 2015-2025
  • Figure 38: Orthobiologics Market, India, Volume (Units), 2015-2025
  • Figure 39: Bone Grafts and Substitutes Market, India, Volume (Units), 2015-2025
  • Figure 40: Bone Growth Stimulators Market, India, Volume (Units), 2015-2025
  • Figure 41: Cartilage Repair Market, India, Volume (Units), 2015-2025
  • Figure 42: Soft Tissue Biologics Market, India, Volume (Units), 2015-2025
  • Figure 43: Viscosupplementation Market, India, Volume (Units), 2015-2025
  • Figure 44: Orthobiologics Market, India, Company Share (%) 2019
  • Figure 45: Orthobiologics Market, Japan, Revenue ($m), USD Constant, 2015-2025
  • Figure 46: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, 2015-2025
  • Figure 47: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, 2015-2025
  • Figure 48: Cartilage Repair Market, Japan, Revenue ($m), USD Constant, 2015-2025
  • Figure 49: Soft Tissue Biologics Market, Japan, Revenue ($m), USD Constant, 2015-2025
  • Figure 50: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, 2015-2025

GlobalData's "Asia - Pacific Orthobiologics Market Outlook to 2025" is a comprehensive databook report, covering key market data on the Asia - Pacific Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Bone Grafts and Substitutes, Bone Growth Stimulators, Cartilage Repair, Soft Tissue Biologics and Viscosupplementation.

The Asia - Pacific Orthobiologics Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the Asia - Pacific Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia - Pacific Orthobiologics is segmented as follows -

  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Cartilage Repair
  • Soft Tissue Biologics
  • Viscosupplementation

Reasons to Buy

The Asia - Pacific Orthobiologics Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Orthobiologics Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, Asia-Pacific

  • 3.1 Orthobiologics Market, Asia-Pacific, Revenue ($m), 2015-2025
  • 3.2 Orthobiologics Market, Asia-Pacific, Revenue ($m), 2015-2025
  • 3.3 Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025
  • 3.4 Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025
  • 3.5 Orthobiologics Market, Asia-Pacific, Company Share by Revenue ($m), 2019

4 Orthobiologics Market, Australia

  • 4.1 Orthobiologics Market, Australia, Revenue ($m), 2015-2025
    • 4.1.1 Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2015-2025
    • 4.1.2 Bone Growth Stimulators Market, Australia, Revenue ($m), by Segment, 2015-2025
    • 4.1.3 Cartilage Repair Market, Australia, Revenue ($m), by Segment, 2015-2025
    • 4.1.4 Soft Tissue Biologics Market, Australia, Revenue ($m), by Segment, 2015-2025
    • 4.1.5 Viscosupplementation Market, Australia, Revenue ($m), by Segment, 2015-2025
  • 4.2 Orthobiologics Market, Australia, Volume (Units), 2015-2025
    • 4.2.1 Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2015-2025
    • 4.2.2 Bone Growth Stimulators Market, Australia, Volume (Units), by Segment, 2015-2025
    • 4.2.3 Cartilage Repair Market, Australia, Volume (Units), by Segment, 2015-2025
    • 4.2.4 Soft Tissue Biologics Market, Australia, Volume (Units), by Segment, 2015-2025
    • 4.2.5 Viscosupplementation Market, Australia, Volume (Units), by Segment, 2015-2025
  • 4.3 Orthobiologics Market, Australia, Average Price ($), 2015-2025
  • 4.4 Orthobiologics Market, Australia, Distribution Share by Revenue ($m), 2019
  • 4.5 Orthobiologics Market, Australia, Company Share by Revenue ($m), 2019

5 Orthobiologics Market, China

  • 5.1 Orthobiologics Market, China, Revenue ($m), 2015-2025
    • 5.1.1 Bone Grafts and Substitutes Market, China, Revenue ($m), by Segment, 2015-2025
    • 5.1.2 Bone Growth Stimulators Market, China, Revenue ($m), by Segment, 2015-2025
    • 5.1.3 Cartilage Repair Market, China, Revenue ($m), by Segment, 2015-2025
    • 5.1.4 Soft Tissue Biologics Market, China, Revenue ($m), by Segment, 2015-2025
    • 5.1.5 Viscosupplementation Market, China, Revenue ($m), by Segment, 2015-2025
  • 5.2 Orthobiologics Market, China, Volume (Units), 2015-2025
    • 5.2.1 Bone Grafts and Substitutes Market, China, Volume (Units), by Segment, 2015-2025
    • 5.2.2 Bone Growth Stimulators Market, China, Volume (Units), by Segment, 2015-2025
    • 5.2.3 Cartilage Repair Market, China, Volume (Units), by Segment, 2015-2025
    • 5.2.4 Soft Tissue Biologics Market, China, Volume (Units), by Segment, 2015-2025
    • 5.2.5 Viscosupplementation Market, China, Volume (Units), by Segment, 2015-2025
  • 5.3 Orthobiologics Market, China, Average Price ($), 2015-2025
  • 5.4 Orthobiologics Market, China, Distribution Share by Revenue ($m), 2019
  • 5.5 Orthobiologics Market, China, Company Share by Revenue ($m), 2019

6 Orthobiologics Market, India

  • 6.1 Orthobiologics Market, India, Revenue ($m), 2015-2025
    • 6.1.1 Bone Grafts and Substitutes Market, India, Revenue ($m), by Segment, 2015-2025
    • 6.1.2 Bone Growth Stimulators Market, India, Revenue ($m), by Segment, 2015-2025
    • 6.1.3 Cartilage Repair Market, India, Revenue ($m), by Segment, 2015-2025
    • 6.1.4 Soft Tissue Biologics Market, India, Revenue ($m), by Segment, 2015-2025
    • 6.1.5 Viscosupplementation Market, India, Revenue ($m), by Segment, 2015-2025
  • 6.2 Orthobiologics Market, India, Volume (Units), 2015-2025
    • 6.2.1 Bone Grafts and Substitutes Market, India, Volume (Units), by Segment, 2015-2025
    • 6.2.2 Bone Growth Stimulators Market, India, Volume (Units), by Segment, 2015-2025
    • 6.2.3 Cartilage Repair Market, India, Volume (Units), by Segment, 2015-2025
    • 6.2.4 Soft Tissue Biologics Market, India, Volume (Units), by Segment, 2015-2025
    • 6.2.5 Viscosupplementation Market, India, Volume (Units), by Segment, 2015-2025
  • 6.3 Orthobiologics Market, India, Average Price ($), 2015-2025
  • 6.4 Orthobiologics Market, India, Distribution Share by Revenue ($m), 2019
  • 6.5 Orthobiologics Market, India, Company Share by Revenue ($m), 2019

7 Orthobiologics Market, Japan

  • 7.1 Orthobiologics Market, Japan, Revenue ($m), 2015-2025
    • 7.1.1 Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2015-2025
    • 7.1.2 Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2015-2025
    • 7.1.3 Cartilage Repair Market, Japan, Revenue ($m), by Segment, 2015-2025
    • 7.1.4 Soft Tissue Biologics Market, Japan, Revenue ($m), by Segment, 2015-2025
    • 7.1.5 Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2015-2025
  • 7.2 Orthobiologics Market, Japan, Volume (Units), 2015-2025
    • 7.2.1 Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2015-2025
    • 7.2.2 Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2015-2025
    • 7.2.3 Cartilage Repair Market, Japan, Volume (Units), by Segment, 2015-2025
    • 7.2.4 Soft Tissue Biologics Market, Japan, Volume (Units), by Segment, 2015-2025
    • 7.2.5 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2015-2025
  • 7.3 Orthobiologics Market, Japan, Average Price ($), 2015-2025
  • 7.4 Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2019
  • 7.5 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2019

8 Orthobiologics Market, South Korea

  • 8.1 Orthobiologics Market, South Korea, Revenue ($m), 2015-2025
    • 8.1.1 Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2015-2025
    • 8.1.2 Bone Growth Stimulators Market, South Korea, Revenue ($m), by Segment, 2015-2025
    • 8.1.3 Cartilage Repair Market, South Korea, Revenue ($m), by Segment, 2015-2025
    • 8.1.4 Soft Tissue Biologics Market, South Korea, Revenue ($m), by Segment, 2015-2025
    • 8.1.5 Viscosupplementation Market, South Korea, Revenue ($m), by Segment, 2015-2025
  • 8.2 Orthobiologics Market, South Korea, Volume (Units), 2015-2025
    • 8.2.1 Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2015-2025
    • 8.2.2 Bone Growth Stimulators Market, South Korea, Volume (Units), by Segment, 2015-2025
    • 8.2.3 Cartilage Repair Market, South Korea, Volume (Units), by Segment, 2015-2025
    • 8.2.4 Soft Tissue Biologics Market, South Korea, Volume (Units), by Segment, 2015-2025
    • 8.2.5 Viscosupplementation Market, South Korea, Volume (Units), by Segment, 2015-2025
  • 8.3 Orthobiologics Market, South Korea, Average Price ($), 2015-2025
  • 8.4 Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), 2019
  • 8.5 Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2019

9 Overview of Key Companies in Asia-Pacific Orthobiologics Market

  • 9.1 DePuy Synthes Inc
    • 9.1.1 Company Overview
  • 9.2 Smith & Nephew Plc
    • 9.2.1 Company Overview
  • 9.3 Sanofi
    • 9.3.1 Company Overview
  • 9.4 Stryker Corp
    • 9.4.1 Company Overview
  • 9.5 Seikagaku Corp
    • 9.5.1 Company Overview
  • 9.6 Zimmer Biomet Holdings Inc
    • 9.6.1 Company Overview
  • 9.7 Medtronic Plc
    • 9.7.1 Company Overview
  • 9.8 Arthrex Inc
    • 9.8.1 Company Overview
  • 9.9 Bloomage Freda Biopharm Co., Ltd
    • 9.9.1 Company Overview
  • 9.10 Bioventus LLC
    • 9.10.1 Company Overview
  • 9.11 Chugai Pharmaceutical Co Ltd
    • 9.11.1 Company Overview

10 Orthobiologics Market Pipeline Products

11 Recent Developments

  • 11.1 Financial Announcements
    • 11.1.1 Feb 04, 2020: Piramal Enterprises announces consolidated results for Q3 & 9M FY2020 ended December 31, 2019

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Coverage
    • 12.1.2 Secondary Research
    • 12.1.3 Primary Research
    • 12.1.4 Market Modeling and Forecasting
    • 12.1.5 Company Share Analysis
    • 12.1.6 Distribution Share Analysis
    • 12.1.7 Benchmarking
  • 12.2 GlobalData Consulting
  • 12.3 Contact Us
  • 12.4 Disclaimer
Back to Top
전화 문의
F A Q